EMBC Share Price Performance
EMBC Community Fair Values
- US$18.33FV45.7% undervalued intrinsic discount0.45%Revenue growth p.a.1users have liked this narrative0users have commented on this narrative6users have followed this narrative3 days ago author updated this narrative
- US$12.00FV17.0% undervalued intrinsic discount-0.035%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative0users have followed this narrative10 days ago author updated this narrative
- US$25.00FV60.2% undervalued intrinsic discount0.54%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative0users have followed this narrative10 days ago author updated this narrative
Recent EMBC News & Updates
No updates
Embecta Corp. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 08, 2025
- Earnings per share (EPS)
- 0.90
- Gross Margin
- 64.06%
- Net Profit Margin
- 4.89%
- Debt/Equity Ratio
- -206.3%
Embecta Corp. Competitors
About EMBC
- Founded
- 1924
- Employees
- 2100
- CEO
- WebsiteView website
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
U.S. Market Performance
- 7 Days: -2.7%
- 3 Months: 10.1%
- 1 Year: 17.7%
- Year to Date: 5.9%
Over the past 7 days, the market has dropped 2.7% with the Financials sector contributing the most to the decline. In the last year, the market is actually up 18%. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading